Sirius Medical, an Eindhoven, Netherlands-based surgical marker navigation company, raised €12M in Series B funding.
The round was led by Holland Capital, with participation from BOM Brabant Ventures, Curie Capital, Team Holmium, and Norgine Ventures.
The company intends to use the funds to accelerate the worldwide growth of their product Pintuition and support further product development, and further commercial roll-out.
Led by CEO Bram Schermers, Sirius Medical is dedicated to improving care for cancer patients by delivery solutions that enable precise and efficient removal of tumors. Its navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and more than 5,000 Pintuition procedures across Western Europe and the US, the company experienced growth in revenue in 2022.
The company is now expanding with over 100 centers and an international sales network in Europe and the USA.
FinSMEs
29/03/2023